Narrative Review: Multi-Omics Has Not Validated Anti-Obesity Drug Selection
A narrative review finds that multi-omics has not yet produced a validated test for selecting anti-obesity medication in people with ...
Tag: incretin therapies
Incretin Drugs Show Heart and Kidney Protection Beyond Blood Sugar Control, Review Finds
A new narrative review finds that GLP-1 receptor agonists and tirzepatide deliver cardiovascular and kidney benefits beyond glucose control, with ...
Weight-Loss Drugs Are Redrawing the Map of Sleep Medicine
A new editorial argues that tirzepatide's approval for obstructive sleep apnea is forcing sleep medicine to define which parts of ...
Tirzepatide Outperforms GLP-1 Drugs on Blood Sugar and Weight, Review Finds
A comparative narrative review finds tirzepatide delivers the largest HbA1c and weight reductions among incretin therapies, while semaglutide leads on ...
Weight Returns Fast After Stopping Ozempic-Style Drugs, Major Analysis Finds
A Bayesian re-analysis of six clinical trials estimates that people who stop semaglutide or tirzepatide regain roughly one kilogram per ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!